Large Employers Cite GLP|1s as Top Factor Driving Up Health Costs

Large Employers Cite GLP-1s as Top Factor Driving Up Health Costs

From 2021 to 2023, the median share of health care dollars that large employers spent on pharmacy costs rose from 21% to 27%, according to ...

Large employers forecast 7.8% hike in health costs next year, thanks ...

The rising burden of pharmaceuticals is expected to be the primary driver of rising healthcare spending in 2025, mostly due to expensive ...

News Briefs: Large Employers Cite GLP-1s as Top Factor Driving Up ...

From 2021 to 2023, the median share of health care dollars that large employers spent on pharmacy costs rose from 21% to 27%.

Weight loss drugs fuel large employers' healthcare cost concerns for ...

The organization's survey of 125 large employers found that 56% said that GLP-1 drugs were impacting their healthcare costs either to a “very great” or “great” ...

Employers Project 8%-9% Rise in Health Care Costs for 2025 - SHRM

Inflation, GLP-1 drugs, and catastrophic medical claims will push employer health care costs significantly higher next year, according to new projections.

Employers Express Concern Over Rising Healthcare Costs, Citing ...

Employers Express Concern Over Rising Healthcare Costs, Citing Specialty Medications Like GLP-1s: Report ... The report also details steps that ...

GLP-1s partly to blame for spike in health insurance costs in 2025

Employer healthcare costs could increase as much as 8% to 9% next year, in part driven by increases in GLP-1 use, according to two new reports.

Employer Coverage of GLP-1 Weight Loss Drugs is on the Rise - CBIZ

A recent survey conducted by the International Foundation of Employee Benefit Plans found that employer coverage of GLP-1 drugs is up 8% since ...

Medical cost trend: Behind the numbers 2025 - PwC

The costs of GLP-1 drugs are on a rising trajectory that impacts overall medical costs. Innovation in prescription drugs for chronic conditions and increasing ...

GLP-1s, Surging Medical Costs Have Employers Taking a Hard ...

Employers ranked the high costs of medical services (68%) and specialty drugs (44%) as their top two healthcare cost management challenges.

Increasing number of employers covering GLP-1 drugs for weight ...

About one-third of US employer health plans now cover GLP-1 drugs for both diabetes and weight management, according to a recent survey.

GLP-1 drugs expected to drive up employer health spending in 2025

Employers are continuing to keep a close eye on GLP-1 weight loss drugs, as they're a major driver of higher prescription drug costs, said Eric ...

Cancer poses a growing problem for employers - Axios

Surging demand for blockbuster GLP-1 weight-loss drugs like Wegovy and Ozempic is helping drive up the cost of workplace insurance, leading some ...

The eight factors that will determine the impact of GLP-1s

Why it matters: With the financial burden of these drugs for patients a major concern (especially given the need to take them into perpetuity), ...

Workers Want Weight-Loss Drugs, But How Can Employers Pay the ...

A survey last fall by the International Foundation of Employee Benefit Plans found that 27% of 205 employers covered GLP-1s for weight loss and ...

How much and why ACA Marketplace premiums are going up in 2025

In addition to GLP-1 drugs, other specialty drugs and biologics, including new gene therapies, are also becoming more prevalent and more costly, ...

GLP-1 Drugs for Weight Loss: What Employers Need to Know

Expert analyses have projected that weight loss drugs have the potential to increase health costs up to $300 per employee per month, depending ...

Employer Healthcare Costs Projected to Hit 10-Year High in 2025

Pharmaceuticals Taking Up Larger Share of Budget. The new survey, in fact, found that while emerging GLP-1 drugs have created challenges for ...

Insurers Say Health Care Costs Will Jump in 2024 - SHRM

Nearly half of insurers (49 percent) also indicated that insured members' poor health habits are among the top factors driving higher health ...

Employer coverage of GLP-1 drugs for weight loss lags far behind ...

In the employee-benefit foundation's survey, employers cited obesity's link with chronic diseases and associated costs as the top factor ...